News

Creating more value.
For doctors and patients

Information from science and research

Stay up to date!

Majority stake in HumanOptics AG to be sold to Chinese investor

Ad-hoc-Mitteilung gemäß Art. 17 MAR

Erlangen, August 30, 2019 - The Management Board of HumanOptics AG ("Company"), a leading technology company for the production of implants for eye surgery, was informed by its current majority shareholder Medipart AG, Unterägeri/Switzerland, ("Medipart") that Medipart signed a share purchase agreement to sell its stake of 73.4% in the share capital of the Company to a Chinese investor today. The closing of the sale is subject to the fulfillment to customary closing conditions, including approvals by Chinese public authorities.

End of the Ad-hoc-Disclosure

Contact:
HumanOptics AG
Investor Relations
Spardorfer Str. 150
91054 Erlangen
Telefon: +49 (0) 9131 50665-0
E-Mail: IR@humanoptics.com

Ad-hoc-Disclosure, 30.08.2019

Archive

HumanOptics international

Wichtige Messetermine

OUR

CUSTOMER SERVICE

YOUR

QUESTIONS

Our experts support you with your questions at any time.

    *Mandatory field

    Company Update: New Sales & Marketing Director at HumanOptics

    News
    News

    With the beginning of the new year, HumanOptics Holding AG welcomes Mr. Christian Eggert to the company. As Sales & Marketing Director, Mr. Eggert will be responsible for the global marketing and sales strategy of the german manufacturer of premium implants for ophthalmic surgery. Christian Eggert, who has driven the international sales strategy of Fritz […]